Post-approval studies (Phase 4)Study completedNCT03156504
What this trial is testing
The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
Who this might be right for
Major DepressionBipolar I DisorderBipolar II Disorder+1 more
Mayo Clinic 75